ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05166	HTLV-I infection	4/22	292/7206	0.0108416210263
ko00524	Neomycin, kanamycin and gentamicin biosynthesis	1/22	4/7206	0.0121587536468
ko04550	Signaling pathways regulating pluripotency of stem cells	3/22	165/7206	0.0131859528979
ko05200	Pathways in cancer	5/22	492/7206	0.0144987310407
ko05224	Breast cancer	3/22	174/7206	0.0152061250258
ko05206	MicroRNAs in cancer	3/22	177/7206	0.0159166711012
ko05217	Basal cell carcinoma	2/22	68/7206	0.0179471138941
ko04390	Hippo signaling pathway	3/22	188/7206	0.0186824094118
ko05202	Transcriptional misregulation in cancer	3/22	188/7206	0.0186824094118
ko00521	Streptomycin biosynthesis	1/22	8/7206	0.0241763136784
ko05218	Melanoma	2/22	85/7206	0.0272626399049
ko01521	EGFR tyrosine kinase inhibitor resistance	2/22	106/7206	0.0408962382222
ko05032	Morphine addiction	2/22	110/7206	0.0437356720133